Clinical Trials on Pharmacokinetic in Canada
Total 22 results
-
Inversago Pharma Inc.Completed
-
Journey Medical CorporationDr. Reddy's Laboratories LimitedCompleted
-
Université de MontréalUnknown
-
Centre hospitalier de l'Université de Montréal...Completed
-
University of AlbertaCompleted
-
Factors Group of Nutritional Companies Inc.CompletedPharmacokineticsCanada
-
Factors Group of Nutritional Companies Inc.CompletedPharmacokineticsCanada
-
Factors Group of Nutritional Companies Inc.Completed
-
Centre hospitalier de l'Université de Montréal...CompletedAnesthesia, Local | PharmacokineticsCanada
-
Endo PharmaceuticalsSFBC AnapharmCompletedPharmacokinetics | Bioavailability | AbsorptionCanada
-
Samuel FortinCompleted
-
Il-Yang Pharm. Co., Ltd.CompletedHealthy | Pharmacokinetics | Pharmacodynamics | IlaprazoleCanada
-
Factors Group of Nutritional Companies Inc.IsuraCompleted
-
Akebia TherapeuticsCompletedPharmacokinetics | Drug Interaction PotentiationCanada
-
Children's Hospital of Eastern OntarioRecruitingPharmacokinetics of Celecoxib in ChildrenCanada
-
University of SaskatchewanSaskatchewan Health Research Foundation; Lung Association of SaskatchewanCompletedPharmacokinetics | Lung Transplant | Kidney TransplantCanada
-
KGK Science Inc.ChromaDex, Inc.CompletedPharmacokineticsCanada
-
Vanda PharmaceuticalsCompletedPharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With EthanolCanada
-
Ottawa Hospital Research InstituteCompletedCritical Illness | Pharmacokinetics | Kidney InjuryCanada
-
PfizerCompletedPharmacokinetics | Safety | ECGCanada, Spain, United States, Hungary, Poland, United Kingdom
-
CytokineticsCompletedChronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | EchocardiogramUnited States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore